Other OTC - Delayed Quote • USD
Q BioMed Inc. (QBIO)
As of May 10 at 9:46 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.15 | -0.11 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 105k | 75k | 196k | 284k |
| Low Estimate | 1M | 3M | 1.55M | 36M |
| High Estimate | 1M | 3M | 1.55M | 36M |
| Year Ago Sales | -- | -- | 30k | 196k |
| Sales Growth (year/est) | -- | -- | 553.30% | 44.90% |
Earnings History
| CURRENCY IN USD | 11/30/2020 | 2/28/2021 | 5/31/2021 | 8/31/2021 |
|---|---|---|---|---|
| EPS Est. | -0.08 | -0.14 | -0.12 | -0.12 |
| EPS Actual | -0.15 | -0.11 | -0.08 | -0.07 |
| Difference | -0.07 | 0.03 | 0.04 | 0.05 |
| Surprise % | -87.50% | 21.40% | 33.30% | 41.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
| 30 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
| 60 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
| 90 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | QBIO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 8.30% |
| Next Qtr. | -- | -- | -- | 11.90% |
| Current Year | -- | -- | -- | 5.60% |
| Next Year | -- | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.05% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Roth Capital: Buy to Neutral | 11/29/2018 |
Related Tickers
AXIM AXIM Biotechnologies, Inc.
0.0090
-10.00%
NBIO Nascent Biotech, Inc.
0.0995
0.00%
UP0.DU Ultragenyx Pharmaceutical Inc
37.40
-0.53%
RDTCF Rapid Dose Therapeutics Corp.
0.0151
0.00%
ORGS Orgenesis Inc.
0.6257
+2.57%
NAVB Navidea Biopharmaceuticals, Inc.
0.0300
-14.29%
OVIT OncoVista Innovative Therapies, Inc.
0.0001
0.00%
NTII Neurobiological Technologies, Inc.
0.0000
0.00%
PMCB PharmaCyte Biotech, Inc.
2.1154
+3.70%
PRED Predictive Technology Group, Inc.
0.0006
0.00%